Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dal Molin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Angewandte Chemie (International Ed. in English)|December 17, 2021
Aquimarins, Peptide Antibiotics with Amino-Modified C-Termini from a Sponge-Derived Aquimarina sp. BacteriumCora L Dieterich, Silke I Probst, Reiko Ueoka, et al.
European Journal of Medicinal Chemistry|September 12, 2024
Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinonesHéctor Torres-Gómez, François Keiff, Peter Hortschansky, et al.
Angewandte Chemie (International Ed. in English)|November 10, 2025
Discovery and Total Synthesis of Crossiguanipyrazines with Potent Activity Against Mycobacterium tuberculosisHaowen Zhao, Etienne Bickel, Jiaqi Liu, et al.
Cell Chemical Biology|January 5, 2024
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion systemRaphael Gries, Jason Chhen, Edeltraud van Gumpel, et al.
Chemmedchem|March 8, 2023
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide BIrina Kollmorgen, Nathalie Bachmann, Michael Dal Molin, et al.
Vaccine|February 7, 2015
Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosisPeter Sander, Simon Clark, Agnese Petrera, et al.
STAR Protocols|March 11, 2025
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosisMarie Sylvianne Rabodoarivelo, Eik Hoffmann, Cyril Gaudin, et al.
European Journal of Medicinal Chemistry|February 20, 2026
Towards selective peptide deformylase inhibitors: A mass spectrometry-based evaluation of in cellulo activity of actinonin and bromoindole derivativesNathalie Bachmann, André Schultz, Manuela Zouatom, et al.
Iscience|April 24, 2023
Implementing best practices on data generation and reporting of <i>Mycobacterium tuberculosis</i> <i>in vitro</i> assays within the ERA4TB consortiumRob C van Wijk, Ainhoa Lucía, Pavan Kumar Sudhakar, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2026
<i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>Marie Sylvianne Rabodoarivelo, Jordana Galizia, Deborah Recchia, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|December 17, 2021
Aquimarins, Peptide Antibiotics with Amino-Modified C-Termini from a Sponge-Derived Aquimarina sp. BacteriumCora L Dieterich, Silke I Probst, Reiko Ueoka, et al.
European Journal of Medicinal Chemistry|September 12, 2024
Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinonesHéctor Torres-Gómez, François Keiff, Peter Hortschansky, et al.
Angewandte Chemie (International Ed. in English)|November 10, 2025
Discovery and Total Synthesis of Crossiguanipyrazines with Potent Activity Against Mycobacterium tuberculosisHaowen Zhao, Etienne Bickel, Jiaqi Liu, et al.
Cell Chemical Biology|January 5, 2024
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion systemRaphael Gries, Jason Chhen, Edeltraud van Gumpel, et al.
Chemmedchem|March 8, 2023
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide BIrina Kollmorgen, Nathalie Bachmann, Michael Dal Molin, et al.
Vaccine|February 7, 2015
Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosisPeter Sander, Simon Clark, Agnese Petrera, et al.
STAR Protocols|March 11, 2025
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosisMarie Sylvianne Rabodoarivelo, Eik Hoffmann, Cyril Gaudin, et al.
European Journal of Medicinal Chemistry|February 20, 2026
Towards selective peptide deformylase inhibitors: A mass spectrometry-based evaluation of in cellulo activity of actinonin and bromoindole derivativesNathalie Bachmann, André Schultz, Manuela Zouatom, et al.
Iscience|April 24, 2023
Implementing best practices on data generation and reporting of <i>Mycobacterium tuberculosis</i> <i>in vitro</i> assays within the ERA4TB consortiumRob C van Wijk, Ainhoa Lucía, Pavan Kumar Sudhakar, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2026
<i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>Marie Sylvianne Rabodoarivelo, Jordana Galizia, Deborah Recchia, et al.
Pageof 3